Investors

Egetis is an innovative, unique, and integrated pharmaceutical drug development company, focusing on projects in late-stage development for treatment of serious rare/niche diseases with significant unmet medical needs in the orphan drug segment

Calendar


December 1, 2022 - Erik Penser Bank Temadag - Healthcare
December 15, 2022 - DNB Nordic Healthcare Conference
February 22, 2023 - Year-end Report Q4 2022

Share

Twitter
LinkedIn

Contact us

Address: Klara Norra Kyrkogata 26, SE 111 22 Stockholm, Sweden

Phone: +46 8 679 72 10

E-mail: info@egetis.com